title: Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics.
authors.affiliation: RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, California 90407-2138, USA.
authors.forename: Yee-Wei
authors.initials: YW
authors.lastname: Lim
authors.forename: Mark
authors.initials: M
authors.lastname: Steinhoff
authors.forename: Federico
authors.initials: F
authors.lastname: Girosi
authors.forename: Douglas
authors.initials: D
authors.lastname: Holtzman
authors.forename: Harry
authors.initials: H
authors.lastname: Campbell
authors.forename: Rob
authors.initials: R
authors.lastname: Boer
authors.forename: Robert
authors.initials: R
authors.lastname: Black
authors.forename: Kim
authors.initials: K
authors.lastname: Mulholland
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D017281:Cost of Illness; D003663:Decision Trees; D003906:Developing Countries; D019937:Diagnostic Techniques and Procedures; D024881:Drug Resistance, Bacterial; D014943:Global Health; D006801:Humans; D007223:Infant; D008828:Microbiological Techniques; D008962:Models, Theoretical; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents